Early Onset of Response to Zasocitinib (TAK-279), a Highly Selective and Potent TYK2 Inhibitor, Is Correlated With Modulation of TYK2 Signaling and Disease Pathway Biomarkers in Patients With Moderate-to-Severe Plaque Psoriasis
DermatologyEarly Onset of Response to Zasocitinib (TAK-279), a Highly Selective and Potent TYK2 Inhibitor, Is Correlated With Modulation of TYK2 Signaling and Disease Pathway Biomarkers in Patients With Moderate-to-Severe Plaque Psoriasis
Once-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
DermatologyOnce-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
Unpacking the Complexity of Psoriatic Arthritis
Living RheumUnpacking the Complexity of Psoriatic Arthritis
Diagnosing Psoriatic Arthritis: A Real-World Case
Living RheumDiagnosing Psoriatic Arthritis: A Real-World Case
Modern Approaches to Psoriatic Arthritis Management
Living RheumModern Approaches to Psoriatic Arthritis Management
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
AudioAbstractsComparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
- advertisement
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CEStuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CENavigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CETargeting CKD-aP at the Source: Key Mechanisms and Treatments
Test Your Skills and Learn From Experts on Best Practice in Diagnosis and Management of Systemic Mastocytosis
CME/CETest Your Skills and Learn From Experts on Best Practice in Diagnosis and Management of Systemic Mastocytosis
Hitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
CME/CEHitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
When Topicals Fail: The New IPC Consensus Every Clinician Should Know
CME/CEWhen Topicals Fail: The New IPC Consensus Every Clinician Should Know
- advertisement
Living with Psoriatic Arthritis: A Doctor-Patient Conversation
Medical Industry FeatureLiving with Psoriatic Arthritis: A Doctor-Patient Conversation
Understanding Dual Inhibition of IL-17
Medical Industry FeatureUnderstanding Dual Inhibition of IL-17
- 04/01/2026
- 03/24/2026
- 03/18/2026
- 03/16/2026
- 03/13/2026
- 03/11/2026